unknown
Stage
1
Investors
About
Dem Biopharma develops first-in-class cancer therapeutics targeting novel mechanisms for solid tumors.
Explore Dem Biopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.